- Home
- SPFI vs TECX Comparison
SPFI vs TECX Comparison
Compare SPFI & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPFI
- TECX
- Stock Information
- Founded
- SPFI 1941
- TECX 2019
- Country
- SPFI United States
- TECX United States
- Employees
- SPFI N/A
- TECX N/A
- Industry
- SPFI Major Banks
- TECX
- Sector
- SPFI Finance
- TECX
- Exchange
- SPFI Nasdaq
- TECX Nasdaq
- Market Cap
- SPFI 647.7M
- TECX 746.6M
- IPO Year
- SPFI 2019
- TECX 2018
- Fundamental
- Price
- SPFI $33.80
- TECX $29.54
- Analyst Decision
- SPFI Buy
- TECX Strong Buy
- Analyst Count
- SPFI 2
- TECX 5
- Target Price
- SPFI $40.50
- TECX $80.50
- AVG Volume (30 Days)
- SPFI 28.7K
- TECX 661.7K
- Earning Date
- SPFI 01-24-2025
- TECX 03-04-2025
- Dividend Yield
- SPFI 1.77%
- TECX N/A
- EPS Growth
- SPFI N/A
- TECX N/A
- EPS
- SPFI 2.92
- TECX N/A
- Revenue
- SPFI $190,870,000.00
- TECX N/A
- Revenue This Year
- SPFI N/A
- TECX N/A
- Revenue Next Year
- SPFI $7.23
- TECX N/A
- P/E Ratio
- SPFI $11.58
- TECX N/A
- Revenue Growth
- SPFI N/A
- TECX N/A
- 52 Week Low
- SPFI $24.05
- TECX $1.40
- 52 Week High
- SPFI $40.91
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- SPFI 36.67
- TECX 38.91
- Support Level
- SPFI $35.09
- TECX $30.42
- Resistance Level
- SPFI $37.35
- TECX $36.11
- Average True Range (ATR)
- SPFI 0.97
- TECX 3.49
- MACD
- SPFI -0.20
- TECX -0.94
- Stochastic Oscillator
- SPFI 0.00
- TECX 0.81
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has two reportable segments: banking and insurance.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.